Company Filing History:
Years Active: 2014-2019
Title: Douglas J. Hodges: Innovator in Antibody Development
Introduction: Douglas J. Hodges is a notable inventor based in Sunnyvale, CA, specializing in the field of antibody research. With a robust portfolio featuring three patents, Hodges is making significant advancements in the treatment of proliferative and immune disorders.
Latest Patents: Among his latest contributions to science, Hodges has developed Anti-GITR antibodies. These antibodies target human GITR (Glucocorticoid-induced TNFR-related protein) and have potential therapeutic applications in managing various immune-related ailments. His work on these antibodies reflects his commitment to addressing critical health challenges through innovative solutions.
Career Highlights: Douglas J. Hodges currently works at Merck Sharp & Dohme Corporation, a leading global healthcare company dedicated to providing innovative medicines. His experience and expertise in antibody research position him as a valuable asset within his organization.
Collaborations: Throughout his career, Hodges has collaborated with notable colleagues including Xiao Min Schebye and Grigori Ermakov. These partnerships are essential in driving forward research initiatives and enhancing the development of groundbreaking therapies.
Conclusion: Douglas J. Hodges continues to make impactful contributions to medical science through his innovative work on antibodies. His dedication to addressing medical challenges showcases the importance of research and collaboration in creating effective treatments for patients.